An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)

Published:2023-10-03 Issue:10 Volume:33 Page:631-649
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Banerjee Suvankar^ORCID,Baidya Sandip Kumar^ORCID,Adhikari Nilanjan^ORCID,Jha Tarun¹^ORCID

Affiliation:

1. Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India

Funder

Jadavpur University

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2023.2284935

Reference110 articles.

1. Matrix Metalloproteinases as Valid Clinical Target

2. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts;Davies B;Cancer Res,1993

3. Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy

4. MMP inhibitors: Glimmers of hope amidst clinical failures

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating UHPLC-Q-TOF-MS/MS, network pharmacology, bioinformatics and experimental validation to uncover the anti-cancer mechanisms of TiaoPi AnChang decoction in colorectal cancer;Journal of Ethnopharmacology;2024-11

2. CCZ1 Accelerates the Progression of Cervical Squamous Cell Carcinoma by Promoting MMP2/MMP17 Expression;Biomedicines;2024-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP